Memory Pharmaceuticals Announces Results for Phase 2a Trial of MEM ... CNNMoney.com - Oct 15, 2007 These and other risks are described in greater detail in Memory Pharmaceuticals' filings with the Securities and Exchange Commission. ... |
Discuss
Add this link to...
Tell a friend
Bury
Comments